Additional Metadata
Persistent URL dx.doi.org/10.1080/10428194.2018.1452215, hdl.handle.net/1765/105762
Journal Leukemia and Lymphoma
Citation
van der Straten, L. (Lina), Dinmohamed, A.G, Westerweel, J, Langerak, A.W, Riedl, J.A, Doorduijn, J.K, … Levin, M.-D. (2018). Rituximab addition to chemotherapy in real world patients with chronic lymphocytic leukemia: effective in first line but indication of lack of efficacy in subsequent lines of therapy. Leukemia and Lymphoma, 1–5. doi:10.1080/10428194.2018.1452215